Hero Technologies Inc. Quarterly Return On Equity in % from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Hero Technologies Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2023.
  • Hero Technologies Inc. Return On Equity for the quarter ending September 30, 2023 was 2.29K %, a 121% increase year-over-year.
  • Hero Technologies Inc. annual Return On Equity for 2022 was 470 %.
  • Hero Technologies Inc. annual Return On Equity for 2015 was -14.7 %, a 603% decline from 2014.
  • Hero Technologies Inc. annual Return On Equity for 2014 was 2.92 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 2.29K +1.25K +121% Jul 1, 2023 Sep 30, 2023
Q2 2023 1.26K Apr 1, 2023 Jun 30, 2023
Q1 2023 338 Jan 1, 2023 Mar 31, 2023
Q4 2022 470 Oct 1, 2022 Dec 31, 2022
Q3 2022 1.03K Jul 1, 2022 Sep 30, 2022
Q1 2016 -17.5 -24.7 -344% Jan 1, 2016 Mar 31, 2016
Q4 2015 -14.7 -17.6 -603% Oct 1, 2015 Dec 31, 2015
Q3 2015 7.23 +15.7 Jul 1, 2015 Sep 30, 2015
Q2 2015 8.04 +20.8 Apr 1, 2015 Jun 30, 2015
Q1 2015 7.17 +13.3 Jan 1, 2015 Mar 31, 2015
Q4 2014 2.92 +7.62 Oct 1, 2014 Dec 31, 2014
Q3 2014 -8.43 -11.7 -360% Jul 1, 2014 Sep 30, 2014
Q2 2014 -12.7 -13.5 -1765% Apr 1, 2014 Jun 30, 2014
Q1 2014 -6.11 -0.55 -9.89% Jan 1, 2014 Mar 31, 2014
Q4 2013 -4.7 +0.49 +9.44% Oct 1, 2013 Dec 31, 2013
Q3 2013 3.25 +12.4 Jul 1, 2013 Sep 30, 2013
Q2 2013 0.76 +2.73 Apr 1, 2013 Jun 30, 2013
Q1 2013 -5.56 -2.56 -85.1% Jan 1, 2013 Mar 31, 2013
Q4 2012 -5.19 Oct 1, 2012 Dec 31, 2012
Q3 2012 -9.1 Jul 1, 2012 Sep 30, 2012
Q2 2012 -1.97 Apr 1, 2012 Jun 30, 2012
Q1 2012 -3.01 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.